IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,817 | -97.2% | 37,762 | -95.6% | 0.00% | -100.0% |
| Q2 2023 | $6,045,642 | -58.1% | 858,756 | -63.6% | 0.01% | -60.0% |
| Q1 2023 | $14,419,301 | -46.5% | 2,359,951 | -44.1% | 0.02% | -50.0% |
| Q4 2022 | $26,977,046 | +4.5% | 4,221,760 | +56.6% | 0.03% | -3.2% |
| Q3 2022 | $25,820,000 | +12.6% | 2,695,220 | +29.7% | 0.03% | +14.8% |
| Q2 2022 | $22,936,000 | +1005.3% | 2,077,531 | +1567.0% | 0.03% | +1250.0% |
| Q1 2022 | $2,075,000 | +6.0% | 124,627 | +21.5% | 0.00% | +100.0% |
| Q4 2021 | $1,957,000 | +98.3% | 102,537 | +156.3% | 0.00% | 0.0% |
| Q3 2021 | $987,000 | -32.4% | 40,014 | -28.7% | 0.00% | -50.0% |
| Q2 2021 | $1,460,000 | -80.6% | 56,086 | -76.4% | 0.00% | -71.4% |
| Q1 2021 | $7,528,000 | +26.0% | 237,769 | +84.6% | 0.01% | +40.0% |
| Q4 2020 | $5,976,000 | +291.4% | 128,781 | +177.6% | 0.01% | +150.0% |
| Q3 2020 | $1,527,000 | +178.1% | 46,390 | +132.0% | 0.00% | +100.0% |
| Q2 2020 | $549,000 | -72.5% | 20,000 | -70.0% | 0.00% | -66.7% |
| Q1 2020 | $1,997,000 | +225.2% | 66,715 | +200.7% | 0.00% | +200.0% |
| Q4 2019 | $614,000 | +139.8% | 22,189 | -2.5% | 0.00% | – |
| Q3 2018 | $256,000 | – | 22,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |